Boston Scientific Corp (BSX.N)

BSX.N on New York Stock Exchange

16 Aug 2019
Change (% chg)

$0.28 (+0.67%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Boston Scientific Corporation is a developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company offers its products by seven businesses: Interventional Cardiology, Cardiac Rhythm Management, Endoscopy, Peripheral Interventions, Urology and Pelvic Health,... (more)


Beta: 0.79
Market Cap(Mil.): $58,810.70
Shares Outstanding(Mil.): 1,390.65
Dividend: --
Yield (%): --


UPDATE 2-Boston Scientific's narrow profit beat fails to excite investors

July 24 Boston Scientific Corp narrowly beat Wall Street estimates for quarterly profit on Wednesday, helped by higher sales of its surgical products used to treat urological and pelvic conditions.

24 Jul 2019

Boston Scientific profit falls 72% on acquisition charges

July 24 U.S. medical device maker Boston Scientific Corp reported a 72.3% drop in second-quarter profit on Wednesday, hit by charges related to its acquisition of Britain's BTG Plc.

24 Jul 2019

Boston Scientific sees $25 mln hit to 2019 revenue from mesh withdrawal

April 17 Boston Scientific Corp on Wednesday said it expects a setback of about $25 million to its full-year revenue due to the U.S. Food and Drugs Administration's order to halt sales of its transvaginal surgical mesh products.

17 Apr 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates